Manufacturer record
Unimarck Healthcare Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
14 batches manufactured by Unimarck Healthcare Ltd (Uttarakhand) were declared Not of Standard Quality between January 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: UGT25954, SITAGLIPTIN PHOSPHATE TABLETS IP 50mg (exp May 2027). DTL, Puducherry (state lab) found it not of standard quality: Failed Description. Listed in the September 2026 alert.
Records by type
14 records linked to Unimarck Healthcare Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| SITAGLIPTIN PHOSPHATE TABLETS IP 50mg | Batch UGT25954Mfg Jun 2025 · Exp May 2027 | Failed DescriptionDescription | DTL, PuducherryState lab | Sep 2026 |
| Labetalol Hydrochloride Tablets IP 100 mg | Batch UGT231341Mfg Oct 2023 · Exp Sep 2025 | Test For Assay(Content) of Labetalol HydrochlorideAssay | Government of NCT of DelhiState lab | Apr 2025 |
| Fexofenadine Hydrochloride Tablets I.P. 120 mg. | Batch UGT231163Mfg Aug 2023 · Exp Jul 2025 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jan 2025 |
| Mesalazine Prolonged-release Tablets IP 1200 mg | Batch UGT23128Mfg Jan 2023 · Exp Dec 2024 | DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2024 |
| Rosuvastatin, Aspirin and Clopidogrel Capsules | Batch UGC22071Mfg Mar 2022 · Exp Feb 2024 | Description, Assay & Dissolution of RosuvastatinAssay | CDL KolkataCDSCO lab | Feb 2023 |
| B-complex capsules | Batch UGC22020Mfg Jan 2022 · Exp Jun 2023 | DescriptionDescription | RDTL GuwahatiState lab | Jan 2023 |
| B-Complex Capsules | Batch UGC22130Mfg Jun 2022 · Exp Nov 2023 | DescriptionDescription | RDTL GuwahatiState lab | Jan 2023 |
| B-Complex Capsules | Batch UGC22131Mfg Jun 2022 · Exp Nov 2023 | DescriptionDescription | RDTL GuwahatiState lab | Jan 2023 |
| B - Complex Capsules | Batch UGC22022Mfg Jan 2022 · Exp Jun 2023 | DescriptionDescription | RDTL GuwahatiState lab | Nov 2022 |
| B - Complex Capsules | Batch UGC22048Mfg Feb 2022 · Exp Jul 2023 | DescriptionDescription | RDTL GuwahatiState lab | Nov 2022 |
| Misoprostol Tablets I.P. 200 mcg | Batch UHT21422Mfg Dec 2021 · Exp Nov 2023 | AssayAssay | CDL KolkataCDSCO lab | Sep 2022 |
| Misoprostol Tablets IP 200mcg | Batch UHT21298Mfg Sep 2021 · Exp Aug 2023 | AssayAssay | RDTL GuwahatiState lab | May 2022 |
| Clidinium Bromide, Chlordiazepoxide and Magnesium Hydroxide Tablets (Ulcon Tablets) | Batch ULGT20031Mfg Jan 2020 · Exp Dec 2021 | Assay of Clidinium BromideAssay | RDTL ChandigarhCDSCO lab | Aug 2020 |
| Pantoprazole Sodium and Domperidone Tablets (PIZA-D TABLETS) | Batch UGT17898Mfg Dec 2017 · Exp Nov 2019 | Assay of DomperidoneAssay | RDTL ChandigarhState lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.